Crispr Therapeutics Ag · NASDAQ:CRSP

Kasinger James R. sold 1,990 Crispr Therapeutics Ag shares (Form 4)

Traded Oct 6, 2026 · Filed Oct 8, 2026

On Oct 6, 2026, Kasinger James R. (General Counsel and Secretary) sold 1,990 Crispr Therapeutics Ag shares at US$60.04 for US$119K under a trading plan, leaving 94,784 shares. Filed Oct 8, 2026 (Form 4).

Sold: 1,990 shares
Price: US$60.04
Value: US$119K
Holding after: 94,784 shares
Trading plan: Yes (Made under a plan set in advance)
Role: General Counsel and Secretary

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 6, 2026	Common Shares	Option exercise	1,990	US$13.62	96,774	Direct
Oct 6, 2026	Common Shares	Sale	1,990	US$60.04	94,784	Direct

Source

View original at SEC

Related